Overview
Maha Metwally practices practicing medicine in Zagazig, Egypt.
Her clinical expertise encompasses Mucormycosis, Muscle Invasive Bladder Cancer, and Hepatocerebral Degeneration.
She is actively involved in clinical research, co-authoring 21 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Maha I. Metwally
Is Maha I. Metwally a top-rated expert for Mucormycosis?
MediFind is an objective health platform that identifies experts based on real-world data. Maha I. Metwally is classified as an Experienced expert for Mucormycosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Maha I. Metwally participate in research or clinical trials?
Yes. Maha I. Metwally has published 21 articles and abstracts on conditions like Mucormycosis. You can view a list of Maha I. Metwally's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Hepatocerebral DegenerationMs. Metwally isExperienced. Learn about Hepatocerebral Degeneration.
- MucormycosisMs. Metwally isExperienced. Learn about Mucormycosis.
- Muscle Invasive Bladder CancerMs. Metwally isExperienced. Learn about Muscle Invasive Bladder Cancer.